Tag: Biotech stocks
Telomerase technology: Good for a Nobel… and for Geron Corporation (GERN)
Published on October 6, 2009
Yesterday, the winners of the Nobel Prize in Medicine were announced: Jack Szostak, Elizabeth Blackburn, and Carol Greider. It was good news for them and great news for Geron Corporation (GERN).
By Laura Cadden, TodaysFinancialNews.com
Baltimore (TFN): The newest recipients of the Nobel Prize in Medicine are credited with the discovery of telomeres – one of [...]
FDA approval in September could boost shares of SPPI and EURX
Published on August 20, 2009
/td>
Earlier this year, FDA approval sent shares of VNDA up 2,602%. Health Canada approval just today sent shares of ANIK up by 74% and counting. We’ve found 2 companies that may get the good news that will send their stocks soaring next month.
TFN eNews 08/19/2009: Better than most $1,000-a-year trading services
Published on August 19, 2009
In today’s TFN eNews:
* Bagging 53.7% on Cerus in 15 days
* When the truth hurts your business
* A new report we’re working on
Dear TFN Reader,
“If you took my advice on July 29 and picked up shares of Cerus Corporation (NASDAQ:CERS), you should be sitting on over 30% gains,” wrote Laura Cadden this [...]
Cerus Corporation (CERS) soars on Swiss approval: HSC members take 53.7% gains in 15 days
Published on August 19, 2009
Great news from Switzerland: Cerus Corporation (NASDAQ:CERS) has gained approval for Intercept. Followers of TFN’s Laura Cadden are rubbing their hands, solid profits jingling in their pockets
by J. Christoph Amberger
Baltimore, MD — TFN: ”If you took my advice on July 29 and picked up shares of Cerus Corporation (NASDAQ:CERS), you should be sitting on over 30% gains,” [...]
25 winning stock recommendations in 2009—for “cumulative gains” of 476%!
Published on May 21, 2009
Stem cell stocks, oil stocks, penny stocks, biotech stocks… in the market mess of 2009, one financial advisory has already closed out 25 recommendations with double-digit gains… or better!
Take over 20% gains on Isis Pharmaceuticals (ISIS)
Published on April 17, 2009
If you bought Isis Pharmaceuticals at our recommended price of under $13, it’s time to gather in the gains!
by Laura Cadden, TodaysFinancialNews.com
Baltimore — (TFN): Back in mid-December, I encouraged TFN readers to buy Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) under $13 and look for double-digit gains to rack up fast.
By January 6 we’d hit over 10%, but [...]
Strategic Options Update: Looking at insurance stocks next week!
Published on March 13, 2009
After a bullish week on Wall Street, we think that insurance companies may be in for a boost next week.
by J. Christoph Amberger
Baltimore—TFN: We have reached the end of a very positive week for Wall Street. All it took was a little good news from the banking industry and the government’s promise to make some well-needed [...]
The best investment opportunity this quarter
Published on March 5, 2009
by Andrew Snyder
280 Investors have already maxed out their profit stake in the most powerful company in the world. When this tiny firm proves its “Genetic Switching” technology, the average investor could see gains of 300%. But make the right moves by May 15 and your investment could surge by over 1,100%!
By May 15, 2009, [...]
Geron Corporation (GERN) up 36% on news of FDA go-ahead
Published on January 24, 2009
One of our top biotech picks, Geron Corporation, is basking in the glory of FDA clearance to begin trials of its human embryonic stem cell-based therapy for patients with acute spinal cord injury.
By Laura Cadden, TodaysFinancialNews.com
Baltimore (TFN): This summer, new sufferers of acute spinal cord injuries may have a greater chance for recovery than their [...]
Four biotechs set to soar
Published on January 12, 2009
Each of these ground-floor stem cell stocks can help you multiply every dollar invested as much as three, four, maybe even ten times!
Reap the gains on TFN’s stem cell stock recommendations!
Published on January 6, 2009
Each of our recommended 3 hottest stem cell stocks has hit at least 20% gains from our original buy price. Enjoy!
By Laura Cadden, TodaysFinancialNews.com
Baltimore — (TFN): Over a month ago, we told you about the 3 Hottest Stem Cell Stocks under $5.
Our report read, “Even a moderate investment may pay off handsomely if the reinstatement [...]
Hold on to Isis Pharmaceuticals (ISIS)
Published on January 6, 2009
We’ve hit the anticipated double-digit gains on Isis Pharmaceuticals. But hold on! There’s more potential upside here…
It’s time to buy Isis Pharmaceuticals (ISIS)
Published on December 17, 2008
The sale of its Ibis Biosciences, Inc. subsidiary to Abbott Labs makes this already promising biopharmaceutical company a good buy right now.
Rest easy with Vanda Pharmaceuticals Inc. (VNDA)
Published on December 2, 2008
This teeny biotech may have struck gold with it’s drug VEC-162. Created to treat insomnia and mood disorders, it’s ability to reset the body’s internal clock could help shift-workers and suffers of jet-lag.
The 3 Hottest Stem Cell Stocks Under $5
Published on November 26, 2008
Each of these ground-floor stem cell stocks can help you multiply every dollar invested as much as three, four, maybe even ten times!
Triple Digit Gains Again and Again
Published on October 8, 2008
Believe it or not, in this nightmare of a market there ARE winners from commodities to energy. Take this company for example, that has repeatedly whipped up gains of 1088%, 777% and 355%.
Technology, banks and commodities have stolen the limelight in the past ten years, but this sector is where huge sums of money have been made and you don’t make money in this business by waiting until after the results are announced.
Small, Undervalued Biotech Stocks Ripe for the Picking
Published on October 1, 2008
A wonder drug for incurable late stage melanoma…a stem cell harvester already granted approval…a cancer diagnostic tool with 98% accuracy…a cash cow stock with a history of acquiring drugs on the cheap with a new one right now!
Technology, banks and commodities have stolen the limelight in the past ten years, but this sector is where huge sums of money have been made and you don’t make money in this business by waiting until after the results are announced.
Biotech firm set to rise: TFN Hot Stock Pick of the Week Video
Published on May 22, 2008
Baltimore — (TFN): The development of cutting-edge biologic drugs that are already improving – even saving – lives marks Osiris Therapeutics as a winner among biotech stocks. Their multi-purpose wonder-drug Prochymal is set to be the first FDA approved stem cell therapy.
Watch the Today’s Financial News video.
****Make sure you sign up for [...]
Biotech Stocks: Opportunities abound for Osiris Therapeutics (OSIR:NASDAQ)
Published on May 22, 2008
A Today’s Financial News Research Report:
‘This Maryland-based biotechnology firm develops treatments for conditions as varied as Crohn’s disease, knee arthritis, tissue damage, life-threatening Graft-versus-host disease and acute radiation syndrome.’ – Laura Cadden
By Laura Cadden, TodaysFinancialNews.com
Today’s Financial News feed provides an independent and practical perspective on the U.S. and global investment markets.
[...]
Follow TFN via RSS or Twitter |
 |
 |
 |
Advertisement
Latest Headlines
- The Big Picture for Sinobiopharma, Inc. (SNBP)
- Beazer Homes USA, Inc. (BZH) and Hovnanian Enterprises, Inc. (HOV) up despite horrid housing news
- The FDA catalyst: 2010 moves in MannKind (MNKD), Roche Holding (RHHBY), Acorda Therapeutics (ACOR) show it still works!
- Steepest drop since Feb. 2009: Here we go again!
- Is the silver run over? Coeur d’Alene Mines (CDE), Silver Wheaton (SLW), Alto Group (ALTO), Hecla Mining (HL), Endeavour Silver (EXK) close down